Department of Pediatric Immunology, Rheumatology and Infectious diseases, Emma Children's Hospital, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands
Department of Pediatric Immunology, Rheumatology and Infectious diseases, Emma Children's Hospital, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands.
Lupus Sci Med. 2022 Feb;9(1). doi: 10.1136/lupus-2021-000572.
To observe if capillary patterns in childhood-onset SLE (cSLE) change over time and find associations between a capillary scleroderma pattern with disease activity, damage or scleroderma-like features.
Clinical and (yearly) capillaroscopy data from a longitudinal cohort of patients with cSLE (minimum of four Systemic Lupus International Collaborating Clinics (SLICC) criteria, onset <18 years) were analysed. Disease activity was measured by Systemic Lupus Erythematosus Activity Index (SLEDAI) and disease damage by SLICC Damage Index. A scleroderma pattern was defined according to the 'fast track algorithm' from the European League Against Rheumatism Study Group on Microcirculation in Rheumatic Diseases. An abnormal capillary pattern, not matching a scleroderma pattern, was defined as 'microangiopathy'.
Our cohort consisted of 53 patients with cSLE with a median disease onset of 14 years (IQR 12.5-15.5 years), median SLEDAI score at diagnosis was 11 (IQR 8-16), median SLEDAI at follow-up was 2 (IQR 1-6). A scleroderma pattern (ever) was seen in 18.9%, while only 13.2% of patients had a normal capillary pattern. Thirty-three patients had follow-up capillaroscopy of which 21.2% showed changes in type of capillary pattern over time. Type of capillary pattern was not associated with disease activity. Raynaud's phenomenon (ever) was equally distributed among patients with different capillaroscopy patterns (p=0.26). Anti-ribonucleoprotein antibodies (ever) were significantly more detected (Χ, p=0.016) in the scleroderma pattern subgroup (n=7 of 10, 70%). Already 5 years after disease onset, more than 50% of patients with a scleroderma pattern had SLE-related disease damage (HR 4.5, 95% CI 1.1 to 18.8, p=0.034), but they did not develop clinical features of systemic sclerosis at follow-up. Number of detected fingers with a scleroderma pattern was similar between cSLE, juvenile systemic sclerosis and juvenile undifferentiated connective tissue disease.
This longitudinal study shows that the majority of capillary patterns in cSLE are abnormal and they can change over time. Irrespective of disease activity, a capillary scleroderma pattern in cSLE may be associated with higher risk of SLE-related disease damage.
观察儿童发病的系统性红斑狼疮 (cSLE) 患者的毛细血管模式是否随时间而变化,并发现硬皮病样毛细血管模式与疾病活动度、损害或硬皮病样特征之间的关联。
对一组儿童发病的 cSLE(至少有 4 项系统性红斑狼疮国际合作临床标准,发病年龄<18 岁)患者的纵向队列进行临床和(每年)毛细血管镜数据分析。采用系统性红斑狼疮活动指数 (SLEDAI) 评估疾病活动度,采用 SLICC 损害指数评估疾病损害。根据欧洲抗风湿病联盟研究小组在风湿病微循环研究中的“快速通道算法”定义硬皮病模式。不符合硬皮病模式的异常毛细血管模式定义为“微血管病”。
我们的队列包括 53 例 cSLE 患者,中位发病年龄为 14 岁(IQR 12.5-15.5 岁),诊断时的中位 SLEDAI 评分为 11(IQR 8-16),随访时的中位 SLEDAI 评分为 2(IQR 1-6)。18.9%的患者出现硬皮病样模式(既往),而仅有 13.2%的患者具有正常毛细血管模式。33 例患者进行了随访毛细血管镜检查,其中 21.2%的患者在随访期间毛细血管模式发生了变化。毛细血管模式与疾病活动度无关。雷诺现象(既往)在不同毛细血管镜模式的患者中分布均匀(p=0.26)。抗核糖核蛋白抗体(既往)在硬皮病模式亚组中明显更多(Χ,p=0.016)(n=10 例中的 7 例,70%)。发病 5 年后,超过 50%的硬皮病模式患者出现与 SLE 相关的疾病损害(HR 4.5,95%CI 1.1-18.8,p=0.034),但在随访时未出现系统性硬化的临床特征。cSLE、幼年型系统性硬皮病和幼年型未分化结缔组织病患者手指的硬皮病模式检出数量相似。
这项纵向研究表明,cSLE 的大多数毛细血管模式异常,且可能随时间而变化。无论疾病活动度如何,cSLE 中的毛细血管硬皮病模式可能与更高的与 SLE 相关的疾病损害风险相关。